Scholtz & Company’s Apyx Medical APYX Stock Holding History
Bought
Maintained
Sold
Other funds holding APYX
ACM
SBCM
Scholtz & Company's APYX Position: Q3 2026 in Review
Scholtz & Company held its Apyx Medical (APYX) position steady in Q3 2026 at 10,000 shares worth $24.5K. The position accounts for 0.01% of the portfolio, ranked #45.
Scholtz & Company first reported a position in APYX in Q1 2023 and has held it in 15 quarters since. The position peaked at $75K in Q2 2023. 68 funds tracked by Wall St. Rank hold APYX as of Q3 2026.
- Scholtz & Company held 10,000 shares of Apyx Medical worth $24.5K as of Q3 2026.
- Scholtz & Company left its Apyx Medical share count unchanged in Q3 2026.
- Apyx Medical made up 0.01% of Scholtz & Company's portfolio in Q3 2026, its #45 holding.
- Scholtz & Company first reported a position in Apyx Medical in Q1 2023 and has held it in 15 quarters since.
- Scholtz & Company's Apyx Medical position peaked at $75K in Q2 2023.
- 68 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2026.
Based on Scholtz & Company's 13F filing for Q3 2026, filed 9 Nov 2026.